Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma

BACKGROUND: Despite the established oncological benefits of neoadjuvant chemotherapy for esophageal squamous cell cancer, not all cases demonstrate benefit. Hence, predicting the response to chemotherapy before treatment is desirable. Some reports have shown that immune factors are related to the ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Surg Oncol
Main Authors: Nakaya, Seiichi, Ogawa, Ryo, Hayakawa, Shunsuke, Fujihata, Shiro, Okubo, Tomotaka, Sagawa, Hiroyuki, Tanaka, Tatsuya, Takahashi, Hiroki, Matsuo, Yoichi, Takiguchi, Shuji
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290605/
https://ncbi.nlm.nih.gov/pubmed/34281546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-021-02290-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados